Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
Accounts Receivables
Adaptive Biotechnologies Corp
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Accounts Receivables
$42m
|
CAGR 3-Years
29%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Accounts Receivables
$9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
Danaher Corp
NYSE:DHR
|
Accounts Receivables
$3.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Accounts Receivables
$650.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
Agilent Technologies Inc
NYSE:A
|
Accounts Receivables
$1.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Accounts Receivables
$3.4B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
See Also
What is Adaptive Biotechnologies Corp's Accounts Receivables?
Accounts Receivables
42m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Accounts Receivables amounts to 42m USD.
What is Adaptive Biotechnologies Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
59%
Over the last year, the Accounts Receivables growth was 36%. The average annual Accounts Receivables growth rates for Adaptive Biotechnologies Corp have been 29% over the past three years , 59% over the past five years .